Back to Research Hub
Protagonist Therapeutics, Inc.
PTGX
$106.03+8.00 (+8.16%)
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases.
StreetsValue research for Protagonist Therapeutics, Inc. (PTGX)
Members get the full report for Protagonist Therapeutics, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.